Status:
UNKNOWN
Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes.
Lead Sponsor:
Hospital de Transplante Doutor Euryclides de Jesus Zerbini
Conditions:
Prostate Cancer
Prostate Adenocarcinoma
Eligibility:
MALE
30+ years
Phase:
NA
Brief Summary
Prostate cancer (PCa) is the most prevalent non cutaneous cancer in occidental countries. In Brazil incidence was about sixty thousand new cases in 2016 and occupied second place as all cancer mortali...
Detailed Description
Prostate cancer (PCa) is the most prevalent non cutaneous cancer in occidental countries. In Brazil incidence was about sixty thousand new cases in 2016 and occupied second place as all cancer mortali...
Eligibility Criteria
Inclusion
- 1\. Patients with recent diagnosis of usual adenocarcinoma of prostate untreated and with indication of specific treatment by the assisting urologist;
- 2\. And low or intermediate prostate cancer in clinical staging;
- 3\. And concordance with the clinical trial by signing the terms.
Exclusion
- 1\. Other types of prostate cancer not usual adenocarcinoma;
- 2\. Or any previous treatment to prostate cancer;
- 3\. Or any patient who presents with proctologic abnormalities;
Key Trial Info
Start Date :
May 31 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT03255135
Start Date
May 31 2018
End Date
July 1 2019
Last Update
June 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Transplantes Euryclides de Jesus Zerbini
São Paulo, Brazil, 01401901